Sahenk, Zarife

Dystrophin Immunity in Duchenne's Muscular Dystrophy

Mendell, J. R., Campbell, K., Rodino-Klapac, L., Sahenk, Z., Shilling, C., Lewis, S., Bowles, D., Gray, S., Li, C., Galloway, G., et al. (2010) · New England Journal of Medicine

Muscle Physiology and DisordersVirus-based gene therapy research

Cited by 655

Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial

Mendell, J. R., Sahenk, Z., Lehman, K., Nease, C., Lowes, L. P., Miller, N. F., Iammarino, M. A., Alfano, L. N., Nicholl, A., Al-Zaidy, S., et al. (2020) · JAMA Neurology

Virus-based gene therapy researchNeurogenetic and Muscular Disorders Research

Cited by 405

Sustained alpha‐sarcoglycan gene expression after gene transfer in limb‐girdle muscular dystrophy, type 2D

Mendell, J. R., Rodino‐Klapac, L. R., Rosales, X. Q., Coley, B. D., Galloway, G., Lewis, S., Malik, V., Shilling, C., Byrne, B. J., Conlon, T., et al. (2010) · Annals of Neurology

Virus-based gene therapy researchMuscle Physiology and Disorders

Cited by 248

Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery

Chicoine, L., Montgomery, C., Bremer, W., Shontz, K., Griffin, D., Heller, K., Lewis, S., Malik, V, Grose, W., Shilling, C., et al. (2014) · Molecular Therapy

Virus-based gene therapy researchNeurogenetic and Muscular Disorders Research

Cited by 167

AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models

Sondergaard, P. C., Griffin, D. A., Pozsgai, E. R., Johnson, R. W., Grose, W. E., Heller, K. N., Shontz, K. M., Montgomery, C. L., Liu, J., Clark, K. R., et al. (2015) · Annals of Clinical and Translational Neurology

Virus-based gene therapy researchNeurogenetic and Muscular Disorders Research

Cited by 99

Axonal tubulin and microtubules: morphologic evidence for stable regions on axonal microtubules

Sahenk, Z., & Brady, S. T. (1987) · Cell Motility

Microtubule and mitosis dynamicsCancer Treatment and Pharmacology

Cited by 59

AAV1.NT3 gene therapy mitigates the severity of autoimmune encephalomyelitis in the mouse model for multiple sclerosis

Tong, L., Ozes, B., Moss, K., Myers, M., Attia, Z., Vetter, T. A., Trapp, B. D., & Sahenk, Z. (2025) · Gene Therapy

Multiple Sclerosis Research StudiesVirus-based gene therapy research

Cited by 8